500 patients67,039 observations150 daysLIVE

Patient P-03411

Synthetic patientONX-7 · Day 145 · 35–44 · M · baseline S07Open companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
47%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S07
  2. Day 90 BR-03 recommendedBehavioural Recommendation BR-03
  3. Day 91 Patient declinedNot now
  4. Day 104 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 104.

Primary contributors, last 14 days
  • GI instability+20
  • Inflammatory activity+17
  • Nutritional resilience-14

What helped?

  • Behavioural Recommendation BR-03Day 90
    Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 60
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Drug metabolism and exposure 35
    • DNADPYD *2A → slower clearance
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Autonomic recovery 25
    • WearableResting HR 76 bpm
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 80/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
45 ms
Sleep
6.9 h
Steps
6,062
Resting HR
74 bpm
Daily log: GI score 33, nutritional resilience 58, adherence 83.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0334350%S1245
P-0327748%S14BR-03improved41
P-0313944%S1342
P-0320244%S1444
P-0342443%S12AD-05improved41
P-0311142%S07AD-05no change48
P-0319742%S1441
P-0320441%S16AD-05improved48
P-0327441%S0840
P-0301440%S0132
P-0314940%S2037
P-0315539%S1456